Regeneron/Sanofi's Largest Selling Drug Dupixent Scores FDA Approval For Infants With Esophagus Inflammation

Thursday, the FDA approved Regeneron Pharmaceutical Inc REGN / Sanofi SA’s SNY Dupixent (dupilumab) for the treatment of pediatric patients aged 1 to 11…

Related Keywords

, Regeneron Pharmaceutical Inc , News , Ggregator , Reaking News , Uration , Media ,